Cargando…
Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell lines
Expression of the protease sensing receptor, protease activated receptor-2 (PAR2), is elevated in a variety of cancers and has been promoted as a potential therapeutic target. With the development of potent antagonists for this receptor, we hypothesised that they could be used to treat renal cell ca...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993771/ https://www.ncbi.nlm.nih.gov/pubmed/33765016 http://dx.doi.org/10.1371/journal.pone.0248983 |